In the fight against Candida albicans resistance and infections, a new strategy is emerging: targeting virulence factors. These are the fungal “weapons” that allow Candida albicans to invade and damage tissues. Drugs that interfere with pleomorphism, biofilm formation, protease synthesis, and adhesion molecules can be developed to disarm the fungus and stop it from doing damage. This strategy could be revolutionary since it targets drug-resistant strains and provides a more focused treatment with fewer adverse effects. Despite ongoing research, virulence factor targeting presents a possible avenue for future Candida albicans resistance.
